An overview on the management of carcinoid tumors.
Napolitano
G
G
Chair of Endocrinology, University G. D'Annunzio, Chieti, Italy.
Bucci
I
I
Lio
S
S
Giuliani
C
C
Minnucci
A
A
Monaco
F
F
D019797:3-Iodobenzylguanidine; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D007462:Iodobenzenes / Q000627:therapeutic use; D015282:Octreotide / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000627:therapeutic use
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D012702:Serotonin Antagonists; D019797:3-Iodobenzylguanidine; D015282:Octreotide